07:41 EDT 24th September 2018 | BioPortfolio

Begun in 1998 and established as an independent venture capital financed operation in 2000, MTI has assembled one of the world's broadest pools of innovative and high-performance corn germplasm.MTI's germplasm was acquired and licensed from private and public sources in Europe and the US, and has already demonstrated its remarkable genetic potential in the company's field testing and product development network in the USA, and in Western and Continental Europe.
MTI's innovative structure of close cooperation with breeding partners creates unmatched cost efficiency in corn genetics R&D. Since 2001, MTI and seed industry collaborators have produced and tested hybrids based on MTI germplasm that are competitive with the best in their class. MTI is already raising the industry hurdle for new high yielding, stress tolerant corn hybrids and cost effective R&D.


Ludwig Boltzmannstraße 2
Neusiedl am See


Phone: 43 (0)5 9010 8170
Fax: 43 (0)5 9010 8171

News Articles [920 Associated News Articles listed on BioPortfolio]

First Zinc-enriched Maize Released in Colombia to Combat Malnutrition

A new variety of zinc-enriched maize was released in Colombia to help fight malnutrition in South America. The new maize variety (BIO-MZN01) was developed by the International Maize and Wheat Improvem...

WEMA Maize Shows Promising Resistance to Fall Armyworm in Mozambique

Early results from the field trials of Water Efficient Maize for Africa (WEMA) show that the genetically modified maize plants are protected against insect pests, even without the use of pesticides. T...

High-protein Maize Shows Resistance to Parasitic Weed

A study by researchers from Africa identified four varieties of high-protein maize, which are resistant to, or tolerant of semi-parasitic weed, Striga.Maize is a widely accepted staple food in many co...

AATF Multi-million Grant for Bt Maize Commercialization in Africa

The African Agricultural Technology Foundation (AATF) received a US$27 million grant from the Bill and Melinda Gates Foundation for the advancement of climate smart maize technologies in Sub-Saharan A...

CIMMYT Scientist Uses Native Maize Varieties to Find Novel Traits for Breeding

A scientist at the International Maize and Wheat Improvement Center (CIMMYT) is working to help farmers face the challenges posed by climate change by using the natural diversity of plants to unlock d...

AATF Receives Multi-million Grant for Bt Maize Commercialization in Africa

The African Agricultural Technology Foundation (AATF) received a US$24.6 million grant from the Bill and Melinda Gates Foundation for the commercialization of insect resistant and drought tolerant mai...

Vietnam farmers show optimism toward planting biotech maize

Planting pest-resistant biotech maize on a large scale will decrease the amount of maize Vietnam needs to import.  -More- 

Vietnamese Farmers Share Experiences in GM Maize Planting

In 2015, Vietnam allowed the cultivation of biotech maize in the country. According to the ISAAA Report for 2017, farmers in Vietnam planted approximately 45,000 hectares of biotech maize. Le Thanh Ha...

PubMed Articles [1103 Associated PubMed Articles listed on BioPortfolio]

The Quantitative Genetic Control of Root Architecture in Maize.

Roots remain an under-explored frontier in plant genetics despite their well-known influence on plant development, agricultural performance, and competition in the wild. Visualizing and measuring root...

Characterization and competitive ability of non-aflatoxigenic Aspergillus flavus isolated from the maize agro-ecosystem in Argentina as potential aflatoxin biocontrol agents.

Aspergillus flavus is an opportunistic pathogen and may produce aflatoxins in maize, one of the most important crops in Argentina. A promising strategy to reduce aflatoxin accumulation is the biologic...

Detection and profiling of circular RNAs in uninfected and maize Iranian mosaic virus-infected maize.

Circular RNAs (circRNAs) are covalently closed non-coding RNAs that are usually derived from exonic regions of genes, but can also arise from intronic and intergenic regions. Studies of circRNAs in hu...

Residue behavior and risk assessment of thifluzamide in the maize field ecosystem.

In the present work, the dissipation kinetics and final residue levels of thifluzamide in the maize field ecosystem were investigated. Using a modified quick, easy, cheap, effective, rugged, and safe ...

Barley stripe mosaic virus (BSMV) as a virus-induced gene silencing vector in maize seedlings.

Barley stripe mosaic virus (BSMV) was the first reported and still widely used virus-induced gene silencing (VIGS) vector for monocotyledons including wheat and barley. Despite BSMV's reported infecti...

Clinical Trials [1503 Associated Clinical Trials listed on BioPortfolio]

Feasibility and Acceptability of a Soy-fiber-maize Complementary Food in Malawi.

The purpose of this intervention study is to assess the feasibility and acceptability of soy-fiber-maize versus soy-maize complementary foods on bowel movement frequency, transit time, gro...

Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status

The purpose of this randomized control trial is to test the impact of provitamin A carotenoid biofortified maize meal consumption on maternal and infant vitamin A status.

Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans

The purpose of this study is to determine how well the body absorbs the carotenoid beta-cryptoxanthin (BCX) from a type of corn that has been naturally bred (not genetically engineered) to...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Effects of Hi-maize Resistant Starch on Insulin Sensitivity

The purpose of this study is to determine the effects of a dietary fiber, resistant starch, on insulin sensitivity. Low insulin sensitivity is a risk factor for some diseases including ty...

Companies [3222 Associated Companies listed on BioPortfolio]

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...


Begun in 1998 and established as an independent venture capital financed operation in 2000, MTI has assembled one of the world's broadest pools of innovative and high-performance corn germplasm.MTI's ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Biomol GmbH

Biomol GmbH: Antibodies, Kits, Arrays and other Reagents for Biomedical Research. We offer high quality reagents and outstanding technical service for the products from our partners Ampliqon, Assay De...

NB Entrepreneurs

NB - A name for Excipients, Microcrystalline Cellulose (MCC), Sodium Starch Glycolate (SSG), Croscarmellose Sodium, Maize Starch, Powdered Cellulose, Cellulose Powder, Spirulina etc. NB has State-of-t...

More Information about "MAIZE TECHNOLOGIES INTERNATIONAL GMBH" on BioPortfolio

We have published hundreds of MAIZE TECHNOLOGIES INTERNATIONAL GMBH news stories on BioPortfolio along with dozens of MAIZE TECHNOLOGIES INTERNATIONAL GMBH Clinical Trials and PubMed Articles about MAIZE TECHNOLOGIES INTERNATIONAL GMBH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MAIZE TECHNOLOGIES INTERNATIONAL GMBH Companies in our database. You can also find out about relevant MAIZE TECHNOLOGIES INTERNATIONAL GMBH Drugs and Medications on this site too.

Quick Search


Relevant Topic

Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...

Corporate Database Quicklinks

Searches Linking to this Company Record